1. Home
  2. FOLD vs SMG Comparison

FOLD vs SMG Comparison

Compare FOLD & SMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • SMG
  • Stock Information
  • Founded
  • FOLD 2002
  • SMG 1868
  • Country
  • FOLD United States
  • SMG United States
  • Employees
  • FOLD N/A
  • SMG N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • SMG Agricultural Chemicals
  • Sector
  • FOLD Health Care
  • SMG Industrials
  • Exchange
  • FOLD Nasdaq
  • SMG Nasdaq
  • Market Cap
  • FOLD 2.9B
  • SMG 3.3B
  • IPO Year
  • FOLD 2007
  • SMG N/A
  • Fundamental
  • Price
  • FOLD $6.12
  • SMG $69.66
  • Analyst Decision
  • FOLD Buy
  • SMG Buy
  • Analyst Count
  • FOLD 10
  • SMG 6
  • Target Price
  • FOLD $16.22
  • SMG $68.17
  • AVG Volume (30 Days)
  • FOLD 5.5M
  • SMG 749.3K
  • Earning Date
  • FOLD 08-07-2025
  • SMG 07-30-2025
  • Dividend Yield
  • FOLD N/A
  • SMG 3.80%
  • EPS Growth
  • FOLD N/A
  • SMG N/A
  • EPS
  • FOLD N/A
  • SMG 0.63
  • Revenue
  • FOLD $543,141,000.00
  • SMG $3,454,700,000.00
  • Revenue This Year
  • FOLD $19.87
  • SMG N/A
  • Revenue Next Year
  • FOLD $23.15
  • SMG $1.96
  • P/E Ratio
  • FOLD N/A
  • SMG $109.82
  • Revenue Growth
  • FOLD 28.25
  • SMG 0.75
  • 52 Week Low
  • FOLD $5.51
  • SMG $45.61
  • 52 Week High
  • FOLD $12.65
  • SMG $93.90
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 51.42
  • SMG 69.05
  • Support Level
  • FOLD $5.66
  • SMG $67.79
  • Resistance Level
  • FOLD $6.45
  • SMG $70.67
  • Average True Range (ATR)
  • FOLD 0.21
  • SMG 1.71
  • MACD
  • FOLD 0.07
  • SMG 0.26
  • Stochastic Oscillator
  • FOLD 64.89
  • SMG 88.50

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About SMG Scotts Miracle-Gro Company (The)

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

Share on Social Networks: